TY - JOUR
T1 - Emerging Technologies for the Diagnosis of Perihilar Cholangiocarcinoma
AU - Rizvi, Sumera
AU - Eaton, John
AU - Yang, Ju Dong
AU - Chandrasekhara, Vinay
AU - Gores, Gregory J.
N1 - Funding Information:
This work was supported by National Institutes of Health grant DK59427 (G.J.G.), and the Mayo Foundation. S. Rizvi also received support from the Cholangiocarcinoma Foundation, the Satter Foundation Liver Cancer Award, and a Pilot & Feasibility Award by the Center for Cell Signaling in Gastroenterology (P30DK084567). We thank Ms. Court-ney Hoover for excellent secretarial support.
Publisher Copyright:
© 2018 by Thieme Medical Publishers, Inc.
PY - 2018/5/1
Y1 - 2018/5/1
N2 - The diagnosis of malignant biliary strictures remains problematic, especially in the perihilar region and in primary sclerosing cholangitis (PSC). Conventional cytology obtained during endoscopic retrograde cholangiography (ERC)-guided brushings of biliary strictures is suboptimal due to limited sensitivity, albeit it remains the gold standard with a high specificity. Emerging technologies are being developed and validated to address this pressing unmet patient need. Such technologies include enhanced visualization of the biliary tree by cholangioscopy, intraductal ultrasound, and confocal laser endomicroscopy. Conventional cytology can be aided by employing complementary and advanced cytologic techniques such as fluorescent in situ hybridization (FISH), and this technique should be widely adapted. Interrogation of bile and serum by examining extracellular vesicle number and cargo, and exploiting next-generation sequencing and proteomic technologies, is also being explored. Examination of circulating cell-free deoxyribonucleic acid (cfDNA) for differentially methylated regions is a promising test which is being rigorously validated. The special expertise required for these analyses has to date hampered their validation and adaptation. Herein, we will review these emerging technologies to inform the reader of the progress made and encourage further studies, as well as adaptation of validated approaches.
AB - The diagnosis of malignant biliary strictures remains problematic, especially in the perihilar region and in primary sclerosing cholangitis (PSC). Conventional cytology obtained during endoscopic retrograde cholangiography (ERC)-guided brushings of biliary strictures is suboptimal due to limited sensitivity, albeit it remains the gold standard with a high specificity. Emerging technologies are being developed and validated to address this pressing unmet patient need. Such technologies include enhanced visualization of the biliary tree by cholangioscopy, intraductal ultrasound, and confocal laser endomicroscopy. Conventional cytology can be aided by employing complementary and advanced cytologic techniques such as fluorescent in situ hybridization (FISH), and this technique should be widely adapted. Interrogation of bile and serum by examining extracellular vesicle number and cargo, and exploiting next-generation sequencing and proteomic technologies, is also being explored. Examination of circulating cell-free deoxyribonucleic acid (cfDNA) for differentially methylated regions is a promising test which is being rigorously validated. The special expertise required for these analyses has to date hampered their validation and adaptation. Herein, we will review these emerging technologies to inform the reader of the progress made and encourage further studies, as well as adaptation of validated approaches.
KW - FISH
KW - cell-free DNA
KW - differentially methylated regions
UR - http://www.scopus.com/inward/record.url?scp=85048251363&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048251363&partnerID=8YFLogxK
U2 - 10.1055/s-0038-1655775
DO - 10.1055/s-0038-1655775
M3 - Article
C2 - 29871021
AN - SCOPUS:85048251363
SN - 0272-8087
VL - 38
SP - 160
EP - 169
JO - Seminars in Liver Disease
JF - Seminars in Liver Disease
IS - 2
ER -